Lisa G Suter1, Claire E Barber2, Jeph Herrin3, Amye Leong4, Elena Losina5, Amy Miller6, Eric Newman7, Mark Robbins8, Heather Tory9, Jinoos Yazdany10. 1. Yale School of Medicine and YNHHSC Center for Outcome Research and Evaluation, New Haven, Connecticut, and VA Connecticut Healthcare System, West Haven. lisa.suter@yale.edu. 2. University of Calgary, Calgary, Alberta, Canada. 3. Yale School of Medicine, New Haven, Connecticut, and Health Research & Educational Trust, Chicago, Illinois. 4. Healthy Motivation, and Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California. 5. Orthopedics and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Harvard Medical School, and Boston University School of Public Health, Boston, Massachusetts. 6. American College of Rheumatology, Atlanta, Georgia. 7. Geisinger Health System, Danville, Pennsylvania. 8. Harvard Vanguard Medical Associates/Atrius Health, Somerville, Massachusetts. 9. Connecticut Children's Medical Center, Hartford, Connecticut, and University of Connecticut School of Medicine, Farmington, Connecticut. 10. University of California, San Francisco.
Abstract
OBJECTIVE: To highlight the opportunities and challenges of developing and implementing performance outcome measures in rheumatology for accountability purposes. METHODS: We constructed a hypothetical performance outcome measure to demonstrate the benefits and challenges of designing quality measures that assess patient outcomes. We defined the data source, measure cohort, reporting period, period at risk, measure outcome, outcome attribution, risk adjustment, reliability and validity, and reporting approach. We discussed outcome measure challenges specific to rheumatology and to fields where patients have predominantly chronic, complex, ambulatory care-sensitive conditions. RESULTS: Our hypothetical outcome measure was a measure of rheumatoid arthritis disease activity intended for evaluating Accountable Care Organization performance. We summarized the components, benefits, challenges, and tradeoffs between feasibility and usability. We highlighted how different measure applications, such as for rapid cycle quality improvement efforts versus pay for performance programs, require different approaches to measure development and testing. We provided a summary table of key take-home points for clinicians and policymakers. CONCLUSION: Performance outcome measures are coming to rheumatology, and the most effective and meaningful measures can only be created through the close collaboration of patients, providers, measure developers, and policymakers. This study provides an overview of key issues and is intended to stimulate a productive dialogue between patients, practitioners, insurers, and government agencies regarding optimal performance outcome measure development.
OBJECTIVE: To highlight the opportunities and challenges of developing and implementing performance outcome measures in rheumatology for accountability purposes. METHODS: We constructed a hypothetical performance outcome measure to demonstrate the benefits and challenges of designing quality measures that assess patient outcomes. We defined the data source, measure cohort, reporting period, period at risk, measure outcome, outcome attribution, risk adjustment, reliability and validity, and reporting approach. We discussed outcome measure challenges specific to rheumatology and to fields where patients have predominantly chronic, complex, ambulatory care-sensitive conditions. RESULTS: Our hypothetical outcome measure was a measure of rheumatoid arthritis disease activity intended for evaluating Accountable Care Organization performance. We summarized the components, benefits, challenges, and tradeoffs between feasibility and usability. We highlighted how different measure applications, such as for rapid cycle quality improvement efforts versus pay for performance programs, require different approaches to measure development and testing. We provided a summary table of key take-home points for clinicians and policymakers. CONCLUSION: Performance outcome measures are coming to rheumatology, and the most effective and meaningful measures can only be created through the close collaboration of patients, providers, measure developers, and policymakers. This study provides an overview of key issues and is intended to stimulate a productive dialogue between patients, practitioners, insurers, and government agencies regarding optimal performance outcome measure development.
Authors: Harlan M Krumholz; Patricia S Keenan; John E Brush; Vincent J Bufalino; Michael E Chernew; Andrew J Epstein; Paul A Heidenreich; Vivian Ho; Frederick A Masoudi; David B Matchar; Sharon-Lise T Normand; John S Rumsfeld; Jeremiah D Schuur; Sidney C Smith; John A Spertus; Mary Norine Walsh Journal: J Am Coll Cardiol Date: 2008-10-28 Impact factor: 24.094
Authors: Jaclyn Anderson; Liron Caplan; Jinoos Yazdany; Mark L Robbins; Tuhina Neogi; Kaleb Michaud; Kenneth G Saag; James R O'Dell; Salahuddin Kazi Journal: Arthritis Care Res (Hoboken) Date: 2012-05 Impact factor: 4.794
Authors: Daniel Aletaha; Valerie P K Nell; Tanja Stamm; Martin Uffmann; Stephan Pflugbeil; Klaus Machold; Josef S Smolen Journal: Arthritis Res Ther Date: 2005-04-07 Impact factor: 5.156
Authors: Lisa G Suter; Shu-Xia Li; Jacqueline N Grady; Zhenqiu Lin; Yongfei Wang; Kanchana R Bhat; Dima Turkmani; Steven B Spivack; Peter K Lindenauer; Angela R Merrill; Elizabeth E Drye; Harlan M Krumholz; Susannah M Bernheim Journal: J Gen Intern Med Date: 2014-05-14 Impact factor: 5.128
Authors: Shanthini Kasturi; Jackie Szymonifka; Jayme C Burket; Jessica R Berman; Kyriakos A Kirou; Alana B Levine; Lisa R Sammaritano; Lisa A Mandl Journal: J Rheumatol Date: 2018-02-01 Impact factor: 4.666
Authors: Ilgin G Arslan; Rianne M Rozendaal; Marienke van Middelkoop; Saskia A G Stitzinger; Maarten-Paul Van de Kerkhove; Vincent M I Voorbrood; Patrick J E Bindels; Sita M A Bierma-Zeinstra; Dieuwke Schiphof Journal: RMD Open Date: 2021-05
Authors: Heather O Tory; Ruy Carrasco; Thomas Griffin; Adam M Huber; Philip Kahn; Angela Byun Robinson; David Zurakowski; Susan Kim Journal: Pediatr Rheumatol Online J Date: 2018-04-19 Impact factor: 3.054
Authors: Zara Izadi; Gabriela Schmajuk; Milena Gianfrancesco; Meera Subash; Michael Evans; Laura Trupin; Jinoos Yazdany Journal: Arthritis Care Res (Hoboken) Date: 2021-12-27 Impact factor: 4.794
Authors: Claire E H Barber; Marinka Twilt; Tram Pham; Gillian R Currie; Susanne Benseler; Rae S M Yeung; Michelle Batthish; Nicholas Blanchette; Jaime Guzman; Bianca Lang; Claire LeBlanc; Deborah M Levy; Christine O'Brien; Heinrike Schmeling; Gordon Soon; Lynn Spiegel; Kristi Whitney; Deborah A Marshall Journal: Arthritis Res Ther Date: 2020-03-19 Impact factor: 5.156